TheProfitWatch

CRVO - CervoMed Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
8.21 -0.17 (-2.07%) --- --- --- --- -0.17 (-2.07%) --- ---

CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
-0.7
Diluted EPS:
Basic P/E:
-11.4857
Diluted P/E:
RSI(14) 1m:
57.22
VWAP:
8.05
RVol:
0.6478

Events

Period Kind Movement Occurred At
1m Price decrease 1m 7.96 -0.14 (-1.78%) Oct 15 13:50
1m Price increase 1m 8.01 +0.1 (+1.26%) Oct 15 13:19
1m Price decrease 1m 8.11 -0.13 (-1.63%) Oct 15 12:03
1m Price decrease 1m 8.19 -0.13 (-1.62%) Oct 15 11:33
10m Price increase 10m 8.35 +0.33 (+4.05%) Oct 15 09:49

Related News